novel immunosuppressive (IS) therapy regimen
Showing 1 - 25 of >10,000
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Erythema, Radiation Therapy, Secondary Skin Reactions Trial in Fort Myers (VS-200Cr, Standard of care)
Not yet recruiting
- Erythema
- Radiation Therapy, Secondary Skin Reactions
- VS-200Cr
- Standard of care
-
Fort Myers, FloridaAdvocate Radiation Oncology
Aug 23, 2023
Multiple Sclerosis Trial in Saint Petersburg (Fludarabine Phosphate for Injection)
Recruiting
- Multiple Sclerosis
- Fludarabine Phosphate for Injection
-
Saint Petersburg, Russian FederationFirst Pavlov State Medical University of St. Petersburg
Apr 14, 2023
Physical Therapy, Total Joint Arthroplasty, Same-day Discharge Trial (Novel same-day discharge protocol after total joint
Not yet recruiting
- Physical Therapy
- +2 more
- Novel same-day discharge protocol after total joint arthroplasty
- Conventional postoperative physical therapy clearance
- (no location specified)
May 10, 2023
Skin Aging Trial in Rochester (Human platelet extract (cosmetic product), Vanicream Gentle Facial Cleanser, EltaMD UV Daily
Completed
- Skin Aging
- Human platelet extract (cosmetic product)
- +4 more
-
Rochester, MinnesotaMayo Clinic
Aug 11, 2022
Severe Aplastic Anemia Trial run by the NHLBI (ATG+Rapamune+cyclosporine, ATG+cyclosporine)
Completed
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021
Renal Insufficiency, Kidney Transplantation Trial in Amsterdam, Groningen, Leiden (tacrolimus OD, mycophenolic acid,
Completed
- Renal Insufficiency
- Kidney Transplantation
- tacrolimus OD, mycophenolic acid, prednisolone
-
Amsterdam, Netherlands
- +2 more
Dec 20, 2021
Molecular Culture for the Diagnosis of Pediatric Sepsis
Not yet recruiting
- Sepsis
- +5 more
- Molecular Culture
- (no location specified)
Aug 29, 2023
COVID-19 Trial (CG-SpikeDown, intranasal formulation, Vehicle (Placebo), Standard of core (type of therapy is depend of decide
Not yet recruiting
- Healthy
- CG-SpikeDown, intranasal formulation
- +2 more
- (no location specified)
Sep 20, 2022
BIOtechnology Applied to Renal TRansplantation With
Recruiting
- Kidney Transplant Failure and Rejection
- Immunobiogram
-
Brasil, Brazil
- +14 more
Apr 14, 2023
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)
Not yet recruiting
- HER2 Positive Advanced Solid Tumors
- HypoSti.CAR-HER2 T cells
- +2 more
- (no location specified)
Jan 12, 2023
Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,
Recruiting
- Rheumatoid Arthritis
- +8 more
- Moderna mRNA-1273
- +5 more
-
Los Angeles, California
- +24 more
Aug 17, 2022
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Renal Allograft Recipients Trial in Worldwide (Belatacept, Tacrolimus, Cyclosporine A)
Recruiting
- Renal Allograft Recipients
- Belatacept
- +5 more
-
Birmingham, Alabama
- +14 more
Oct 24, 2022
HIV-infected Participants With Latent TB Infection in High TB Burden Country Trial in Thailand (Isoniazid/Rifapentine daily (4
Recruiting
- HIV-infected Participants With Latent TB Infection in High TB Burden Country
- Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
- Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
-
Bangkok, Thailand
- +15 more
Mar 22, 2022
Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)
Not yet recruiting
- Recurrent Classic Hodgkin Lymphoma
- Refractory Classic Hodgkin Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- +13 more
- (no location specified)
Feb 2, 2023
Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)
Recruiting
- Sickle Cell Disease
- Hematopoietic stem cell transplantation
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases Trial in Boston (Belumosudil, Fluticasone,
Not yet recruiting
- Bronchiolitis Obliterans Syndrome
- +3 more
- Belumosudil
- +4 more
-
Boston, Massachusetts
- +3 more
Jun 27, 2023
De Novo Metabolic Syndrome in Liver Transplant Patients After
Completed
- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
-
Rome, ItalyRoberta Angelico
Mar 29, 2023
Renal Failure, Renal Insufficiency, Renal Disease Trial in Dresden (Advagraf)
Active, not recruiting
- Renal Failure
- +3 more
-
Dresden, GermanyUniversitätsklinikum Carl Gustav Carus
Aug 2, 2022
Grade IV Astrocytoma, Glioblastoma Trial in France (Temozolomide, folinic acid at pharmacological dose is the escalated drug,
Terminated
- Grade IV Astrocytoma
- Glioblastoma
- Temozolomide
- +2 more
-
Angers, France
- +3 more
May 20, 2021
CNS Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Xi'an (TBF regimen, modified BuCY2 regimen)
Not yet recruiting
- Central Nervous System Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- TBF regimen
- modified BuCY2 regimen
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022